Could Gilead Sciences Have an HIV Cure Waiting in the Wings?

Most of the enthusiasm for Gilead Sciences (NASDAQ: GILD) in recent months has focused on the antiviral drug Remdesivir. Gilead was also in the headlines last week after reports surfaced that the large pharmaceutical company AstraZeneca was interested in taking over the biotechnology. Could Gilead Sciences have an HIV cure ready?
Mention your own website in this post for Advertisement

Last News

‘Gorilla hail’ pounded parts of Texas. See photos and video from the powerful storm

Lil Nas X Asks Fans to Stream "Call Me By Your Name" After Claiming 'It May No Longer Be Available' on Streaming

Ford Bronco drops Vermont Off-Roadeo site after locals object

Former L.A. Sheriff's Deputy Sentenced to Seven Years After Leading Fake Raid For Half Ton of Marijuana

GM Designer Renders New Front-Engine Corvette

4 Delicious Ways to Use Salad Dressing—That Aren’t on Salad